Logo image of CREX

CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CREX - US22530J3095 - Common Stock

2.56 USD
-0.08 (-3.03%)
Last: 12/30/2025, 4:30:01 PM
Fundamental Rating

3

CREX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 95 industry peers in the Media industry. CREX may be in some trouble as it scores bad on both profitability and health. CREX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CREX was profitable.
In the past year CREX has reported a negative cash flow from operations.
In multiple years CREX reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

CREX has a Return On Assets of -14.93%. This is in the lower half of the industry: CREX underperforms 70.53% of its industry peers.
With a Return On Equity value of -41.80%, CREX is not doing good in the industry: 62.11% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROIC N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

With a Gross Margin value of 43.13%, CREX perfoms like the industry average, outperforming 51.58% of the companies in the same industry.
CREX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CREX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CREX has more shares outstanding than it did 1 year ago.
CREX has more shares outstanding than it did 5 years ago.
CREX has a worse debt/assets ratio than last year.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CREX has an Altman-Z score of -0.52. This is a bad value and indicates that CREX is not financially healthy and even has some risk of bankruptcy.
CREX has a worse Altman-Z score (-0.52) than 71.58% of its industry peers.
CREX has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.01, CREX perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z -0.52
ROIC/WACCN/A
WACC7.26%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.03 indicates that CREX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.03, CREX is in line with its industry, outperforming 43.16% of the companies in the same industry.
CREX has a Quick Ratio of 1.03. This is a bad value and indicates that CREX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.77, CREX is not doing good in the industry: 68.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.77
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

CREX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
The Revenue for CREX has decreased by -18.37% in the past year. This is quite bad
The Revenue has been growing by 9.98% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%

3.2 Future

The Earnings Per Share is expected to grow by 66.98% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 32.68% on average over the next years. This is a very strong growth
EPS Next Y-97.82%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.29, which indicates a rather expensive current valuation of CREX.
71.58% of the companies in the same industry are more expensive than CREX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CREX to the average of the S&P500 Index (26.84), we can say CREX is valued slightly cheaper.
The Price/Forward Earnings ratio is 9.84, which indicates a very decent valuation of CREX.
Based on the Price/Forward Earnings ratio, CREX is valued a bit cheaper than the industry average as 71.58% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CREX to the average of the S&P500 Index (23.40), we can say CREX is valued rather cheaply.
Industry RankSector Rank
PE 18.29
Fwd PE 9.84
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CREX indicates a slightly more expensive valuation: CREX is more expensive than 66.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 101.5
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

CREX's earnings are expected to grow with 66.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CREX!.
Industry RankSector Rank
Dividend Yield 0%

CREATIVE REALITIES INC

NASDAQ:CREX (12/30/2025, 4:30:01 PM)

2.56

-0.08 (-3.03%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-12 2026-03-12/bmo
Inst Owners15.19%
Inst Owner Change-23.71%
Ins Owners17.24%
Ins Owner Change21.85%
Market Cap26.93M
Revenue(TTM)44.32M
Net Income(TTM)-9.15M
Analysts84
Price Target8.29 (223.83%)
Short Float %1.47%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-116.19%
Min EPS beat(2)-149.99%
Max EPS beat(2)-82.4%
EPS beat(4)1
Avg EPS beat(4)57.24%
Min EPS beat(4)-149.99%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-6.96%
Max Revenue beat(2)6.23%
Revenue beat(4)2
Avg Revenue beat(4)-2%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)4
Avg Revenue beat(8)-2.2%
Revenue beat(12)4
Avg Revenue beat(12)-4.14%
Revenue beat(16)4
Avg Revenue beat(16)-3.48%
PT rev (1m)13.04%
PT rev (3m)22.64%
EPS NQ rev (1m)-519.92%
EPS NQ rev (3m)-333.33%
EPS NY rev (1m)-724.39%
EPS NY rev (3m)-633.33%
Revenue NQ rev (1m)15.57%
Revenue NQ rev (3m)41.39%
Revenue NY rev (1m)12.01%
Revenue NY rev (3m)6.38%
Valuation
Industry RankSector Rank
PE 18.29
Fwd PE 9.84
P/S 0.61
P/FCF N/A
P/OCF N/A
P/B 1.23
P/tB N/A
EV/EBITDA 101.5
EPS(TTM)0.14
EY5.47%
EPS(NY)0.26
Fwd EY10.16%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS4.21
BVpS2.08
TBVpS-1.9
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.56
Profitability
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.13%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score2
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA 46.08
Cap/Depr 51.44%
Cap/Sales 5.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.77
Altman-Z -0.52
F-Score2
WACC7.26%
ROIC/WACCN/A
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
EPS Next Y-97.82%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A
EBIT growth 1Y-219.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year484.05%
EBIT Next 3Y202.07%
EBIT Next 5YN/A
FCF growth 1Y-208.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-125.48%
OCF growth 3Y93.04%
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to CREX.


What is the valuation status for CREX stock?

ChartMill assigns a valuation rating of 4 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Fairly Valued.


What is the profitability of CREX stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for CREX stock?

The Earnings per Share (EPS) of CREATIVE REALITIES INC (CREX) is expected to decline by -97.82% in the next year.